机构名称：
¥ 2.0
Cautionary Notice Regarding Forward-Looking Statements All statements in this press release, other than statements of historical fact, are statements that could be deemed “forward-looking statements” In some cases, forward-looking statements may be identified by terminology such as “believe,” “may,” “will,” “should”, “predict”, “goal”, “strategy”, “potentially,” “estimate,” “continue,” “anticipate,” “打算”，“可以”，“会”，“项目”，“计划”，“期望”，“寻求”以及类似的表达方式和变化。iveric Bio打算将这些前瞻性陈述由安全港的规定涵盖美国的前瞻性陈述1995年的私人证券诉讼改革法案。本新闻稿包含与拟议中的“前瞻性陈述”，其中包含拟议的对艾维拉斯的生物的收购以及此类拟议的收购，阿斯特拉斯的目标，阿斯特拉斯和艾维利奇生物的信念和期望的目标和期望。 Bio，Iveric Bio的产品候选人的预期收益和成功，批准ACP的可能性和预期时间的潜力，预期的拟议收购融资以及拟议中的收购的预期时间，每种都会涉及实质性的风险和不确定性，这些风险可能会导致与那些明确或暗示的那些人属于这些表达或暗示的实际结果。此外，Astellas和Iveric Bio在竞争性和快速变化的环境中运作，并不时出现新的风险。上述因素并不详尽。Astellas and Iveric Bio have based these forward- looking statements on their current expectations and projections about future events and trends that they believe may affect the financial condition, results of operations, business strategy, short- term and long-term business operations and objectives and financial needs of Astellas and Iveric Bio, but they cannot guarantee future events, results, actions, levels of activity, performance or achievements, business and market conditions, the timing and results of biotechnology development and潜在的监管批准。您还应仔细考虑可能影响Iveric Bio业务的其他风险和不确定性，包括“前瞻性陈述”，“主要风险因素的摘要”中所述的风险和不确定性，“主要风险因素的摘要”以及“ Iveric Biio Biio在表格10-K上的年度报告”的“风险因素”部分，表格10-Q的每季度报告和其他文档的季度报告和其他时间为SECT的网站。这些文件识别并解决了可能导致实际事件和结果与前瞻性陈述中包含的事件和结果的其他重要风险和不确定性。前瞻性陈述仅在制作之日起说话。读者被告知不要不依赖前瞻性陈述，astellas和iveric Bio不承担任何义务，也不打算更新或修改这些前瞻性陈述，无论是由于新信息，未来事件还是其他方式，除非适用法律，否则
获得IVERIC BIO
主要关键词
相关文件推荐
